PDPL

Parenteral Drugs (India) Ltd.

Share on:

Stock score

Download the app

and get exclusive insights on the stock

Stock highlights

Stock Sentiment

Bullish

Buyers are optimistic about the price rise, stock is in uptrend

Profits

169.0%

Profit increased as compared to last quarter

Market Pricing

Fairly valued

Stock is trading at reasonable price

Fundamentals

Small-Cap

Pharmaceuticals & Drugs

P/E Ratio

Sector P/E

55.84

Dividend yield

Market cap

₹ 13 Cr

Financials

all values are in ₹ Cr

Shareholding

FII

Retail & Other

Promoter

Domestic Institution

PDPL